In a small cohort, Thomas Zeller, Universitäts-Herzzentrum, Bad Krozingen, Germany, and colleagues, investigated the use of the Proteus embolic capture angioplasty balloon for peripheral vascular disease. They reported on their initial experience using the angioplasty balloon in a study published in the Journal of Endovascular Therapy.
The Society for Cardiovascular Angiography and Interventions (SCAI) has released a statement in response to a study showing that minimally invasive procedures significantly lower health payer costs and result in fewer missed workdays when compared to open surgery. The study by Andrew J. Epstein, PhD, et al was published online ahead of print in Journal of the American Medical Association (JAMA) Surgery.
El tratamiento con células de médula ósea autólogas podría reducir las amputaciones en los pacientes con isquemia de miembros inferiores crítica (IMIC).
Los bebés nacidos de mujeres obesas típicamente presentan un engrosamiento de un vaso sanguíneo clave del corazón que parece relacionares con el peso excesivo de sus madres
El uso de aspirina a largo plazo podría aumentar ligeramente el riesgo de desarrollar degeneración macular relacionada con la edad, una importante causa de ceguera entre las personas mayores, sugiere un estudio reciente.
Lombard Medical Technologies announced on 15 February 2013 that Aorfix has been approved for commercial sale in the USA by the FDA. Aorfix is the company’s flexible stent graft for the endovascular repair of abdominal aortic aneurysms. Data from the US PYTHAGORAS trial of Aorfix, has demonstrated that Aorfix can successfully treat a larger patient population than competing devices, including both standard and difficult to treat cases of abdominal aortic aneurysm.
Los diabéticos que se someten a una angioplastia coronaria primaria registran menos revascularizaciones del vaso tratado cuando se utilizan stents liberadores de fármacos (DES, por su sigla en inglés) en lugar de stents metálicos (BMS, por su sigla en inglés)
Konstantinos P Donas, Clinic for Vascular and Endovascular Surgery, Münster University Hospital and St Franziskus Hospital, Münster, Germany, and colleagues have found that the use of chimney and/or periscope endografts for pararenal aortic pathologies achieves and maintains successful exclusion of aneurysms in 90% of the cases at 24 months of radiological follow-up.
At the LINC congress (Leipzig, Germany, 23–26 January), Dierk Scheinert, Park Hospital Leipzig, Germany, presented the details of a new randomised controlled trial that will evaluate a drug-eluting stent vs. paclitaxel-eluting balloons for the treatment of symptomatic femoropopliteal artery disease.
With more than 100 patients enrolled,Cook Medical announced on 5 February 2013 it has exceeded 50% enrolment in the Tibiopedal Access for Crossing of Infrainguinal Artery Occlusions trial. The first-of-its-kind, prospective, multicentre study is evaluating the retrograde tibiopedal vascular access technique for treating critical limb ischaemia.
Medtronic has announced the CE mark and international launch of its Complete SE self-expanding vascular stent for use in the lower extremities, specifically, the superficial femoral arteries and proximal popliteal arteries.
Covidien has announced CE mark approval for its EverFlex Self-Expanding Peripheral Stent with Entrust Delivery System.
On 5 February 2013, IDEV Technologies announced the publication of positive clinical outcomes for the Supera peripheral stent system in the Journal of American College of Cardiology (JACC) Cardiovascular Interventions. The publication, “Treatment of Complex Atherosclerotic Popliteal Artery Disease with a New Self-Expanding Interwoven Nitinol Stent: 12-Month Results of the Leipzig Supera Popliteal Registry,” was authored by Dierk Scheinert and colleagues from Park Krankenhaus Hospital in Leipzig, Germany.
Daiichi Sankyo Europe announced the enrolment of the first patient into the PREFER in VTE (Prevention of thromboembolic events – European registry in venous thromboembolism) study on 6 February 2013. PREFER in VTE is the first patient registry to gather comprehensive data on the quality of life and treatment satisfaction of patients with venous thromboembolism (VTE). It will also provide detailed insights into the process of patient management in the acute treatment phase, as well as in the prevention of repeat thromboembolic events. In addition, the PREFER in VTE registry will investigate the economic burden of venous thromboembolism treatment.
Medtronic has announced completion of enrolment in IN.PACT SFA II, the US arm of its clinical study for the IN.PACT Admiral drug-eluting balloon as a treatment for peripheral arterial disease in the superficial femoral and proximal popliteal arteries.
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos